Variant report

Variant	esv3340220
Chromosome Location	chr6:1388928-1391901
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr6:1389801-1389934	H1-hESC	embryonic stem cell:	n/a	n/a
2	BRCA1	chr6:1391177-1391516	Hela-S3	cervix:	n/a	n/a
3	CEBPB	chr6:1391227-1391372	Hela-S3	cervix:	n/a	n/a
4	CEBPB	chr6:1389779-1390104	HepG2	liver:	n/a	chr6:1389929-1389938 chr6:1389929-1389938 chr6:1389929-1389938 chr6:1389929-1389938
5	CEBPB	chr6:1389752-1390118	HepG2	liver:	n/a	chr6:1389929-1389938 chr6:1389929-1389938 chr6:1389929-1389938 chr6:1389929-1389938
6	CEBPB	chr6:1389808-1390073	HepG2	liver:	n/a	chr6:1389929-1389938 chr6:1389929-1389938 chr6:1389929-1389938 chr6:1389929-1389938
7	CEBPB	chr6:1389802-1389972	HepG2	liver:	n/a	chr6:1389929-1389938 chr6:1389929-1389938 chr6:1389929-1389938 chr6:1389929-1389938
8	CEBPB	chr6:1389743-1390112	K562	blood:	n/a	chr6:1389929-1389938 chr6:1389929-1389938 chr6:1389929-1389938 chr6:1389929-1389938
9	CEBPB	chr6:1389781-1390116	A549	lung:	n/a	chr6:1389929-1389938 chr6:1389929-1389938 chr6:1389929-1389938 chr6:1389929-1389938
10	CEBPB	chr6:1389728-1390126	A549	lung:	n/a	chr6:1389929-1389938 chr6:1389929-1389938 chr6:1389929-1389938 chr6:1389929-1389938
11	CEBPB	chr6:1389787-1390147	ECC-1	luminal epithelium:	n/a	chr6:1389929-1389938 chr6:1389929-1389938 chr6:1389929-1389938 chr6:1389929-1389938
12	CEBPB	chr6:1389738-1390126	Hela-S3	cervix:	n/a	chr6:1389929-1389938 chr6:1389929-1389938 chr6:1389929-1389938 chr6:1389929-1389938
13	CEBPB	chr6:1389752-1390066	H1-hESC	embryonic stem cell:	n/a	chr6:1389929-1389938 chr6:1389929-1389938 chr6:1389929-1389938 chr6:1389929-1389938
14	CEBPB	chr6:1389739-1390124	IMR90	lung:	n/a	chr6:1389929-1389938 chr6:1389929-1389938 chr6:1389929-1389938 chr6:1389929-1389938
15	CEBPD	chr6:1389791-1390068	HepG2	liver:	n/a	chr6:1389929-1389938
16	CHD1	chr6:1388277-1394777	IMR90	lung:	n/a	chr6:1389414-1389424
17	CHD2	chr6:1390563-1390853	Hela-S3	cervix:	n/a	n/a
18	CHD2	chr6:1391183-1391493	H1-hESC	embryonic stem cell:	n/a	n/a
19	CHD2	chr6:1389586-1389939	Hela-S3	cervix:	n/a	n/a
20	CHD2	chr6:1391124-1391742	Hela-S3	cervix:	n/a	n/a
21	CHD2	chr6:1389654-1389701	H1-hESC	embryonic stem cell:	n/a	n/a
22	CTBP2	chr6:1389053-1391565	H1-hESC	embryonic stem cell:	n/a	n/a
23	CTCF	chr6:1390767-1390803	Fibrobl	skin:	n/a	n/a
24	CTCF	chr6:1390440-1390590	HEK293	kidney:	n/a	n/a
25	CTCF	chr6:1390540-1390690	WERI-Rb-1	eye:	n/a	n/a
26	CTCF	chr6:1390680-1390830	Hela-S3	cervix:	n/a	n/a
27	CTCF	chr6:1390688-1390699	Fibrobl	skin:	n/a	n/a
28	E2F1	chr6:1389765-1391236	Hela-S3	cervix:	n/a	chr6:1390438-1390449 chr6:1390075-1390084
29	E2F4	chr6:1390476-1390673	MCF10A-Er-Src	breast:	n/a	n/a
30	E2F6	chr6:1391056-1391474	H1-hESC	embryonic stem cell:	n/a	n/a
31	E2F6	chr6:1390653-1391041	A549	lung:	n/a	n/a
32	E2F6	chr6:1390545-1391073	A549	lung:	n/a	n/a
33	EGR1	chr6:1389510-1389830	H1-hESC	embryonic stem cell:	n/a	n/a
34	EGR1	chr6:1390356-1390976	H1-hESC	embryonic stem cell:	n/a	n/a
35	EGR1	chr6:1389436-1390223	H1-hESC	embryonic stem cell:	n/a	n/a
36	FOXP2	chr6:1389567-1390057	PFSK-1	brain:	n/a	n/a
37	GABPA	chr6:1390423-1390930	H1-hESC	embryonic stem cell:	n/a	n/a
38	GTF2F1	chr6:1391424-1391866	Hela-S3	cervix:	n/a	n/a
39	HA-E2F1	chr6:1389604-1391383	Hela-S3	cervix:	n/a	chr6:1390438-1390449 chr6:1390075-1390084
40	HDAC2	chr6:1389744-1390067	HepG2	liver:	n/a	n/a
41	KAP1	chr6:1388459-1388943	U2OS	brain:	n/a	n/a
42	KAP1	chr6:1388407-1389000	HEK293	kidney:	n/a	n/a
43	MAX	chr6:1390371-1391566	Hela-S3	cervix:	n/a	n/a
44	MAX	chr6:1390742-1391488	H1-hESC	embryonic stem cell:	n/a	n/a
45	MAX	chr6:1390260-1391091	A549	lung:	n/a	n/a
46	MAX	chr6:1390304-1390971	ECC-1	luminal epithelium:	n/a	n/a
47	MAX	chr6:1390721-1390990	A549	lung:	n/a	n/a
48	MAX	chr6:1389680-1390062	Hela-S3	cervix:	n/a	n/a
49	MAX	chr6:1390577-1391547	H1-hESC	embryonic stem cell:	n/a	n/a
50	MAX	chr6:1390082-1391224	A549	lung:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:1389367-1389417	RPTEC	kidney:	n/a
2	chr6:1389367-1389417	HCT-116	colon:	n/a
3	chr6:1389167-1389217	HPAEpiC	pulmonary alveolar:	n/a
4	chr6:1390998-1391048	GM12892	blood:	n/a
5	chr6:1390622-1390672	HIPEpiC	eye:	n/a
6	chr6:1390622-1390672	BJ	skin:	n/a
7	chr6:1390998-1391048	GM06990	blood:	n/a
8	chr6:1390998-1391048	CMK	blood:	n/a
9	chr6:1391758-1391808	HAEpiC	amniotic membrane:	n/a
10	chr6:1389146-1389196	IMR90	lung:	fetal
11	chr6:1389167-1389217	LNCaP	prostate:	n/a
12	chr6:1390838-1390888	HPAEpiC	pulmonary alveolar:	n/a
13	chr6:1390622-1390672	HL-60	blood:	n/a
14	chr6:1389146-1389196	ProgFib	skin:	n/a
15	chr6:1391207-1391257	Hela-S3	cervix:	n/a
16	chr6:1389146-1389196	BJ	skin:	n/a
17	chr6:1389367-1389417	SKMC	muscle:	n/a
18	chr6:1389966-1390016	ovcar-3	ovarian:	n/a
19	chr6:1389966-1390016	GM12892	blood:	n/a
20	chr6:1389966-1390016	GM19239	blood:	n/a
21	chr6:1389167-1389217	Caco-2	colon:	n/a
22	chr6:1389146-1389196	NT2-D1	testis:	n/a
23	chr6:1391207-1391257	HNPCEpiC	eye:	n/a
24	chr6:1390622-1390672	ovcar-3	ovarian:	n/a
25	chr6:1390998-1391048	ECC-1	luminal epithelium:	n/a
26	chr6:1389146-1389196	HMEC	breast:	n/a
27	chr6:1391758-1391808	AG09309	skin:	n/a
28	chr6:1390998-1391048	Hepatocyte	liver:	n/a
29	chr6:1389966-1390016	AG09319	gingival:	n/a
30	chr6:1389146-1389196	HUVEC	blood vessel:	n/a
31	chr6:1390361-1390411	HNPCEpiC	eye:	n/a
32	chr6:1391265-1391315	BJ	skin:	n/a
33	chr6:1390361-1390411	ProgFib	skin:	n/a
34	chr6:1391265-1391315	HCF	heart:	n/a
35	chr6:1390622-1390672	HNPCEpiC	eye:	n/a
36	chr6:1389367-1389417	HIPEpiC	eye:	n/a
37	chr6:1390361-1390411	ECC-1	luminal epithelium:	n/a
38	chr6:1389367-1389417	HepG2	liver:	n/a
39	chr6:1391758-1391808	PFSK-1	brain:	n/a
40	chr6:1390622-1390672	HUVEC	blood vessel:	n/a
41	chr6:1389146-1389196	GM12891	blood:	n/a
42	chr6:1389167-1389217	ProgFib	skin:	n/a
43	chr6:1391758-1391808	HEEpiC	esophagus:	n/a
44	chr6:1389966-1390016	PrEC	prostate:	n/a
45	chr6:1390361-1390411	MCF-7	breast:	n/a
46	chr6:1389966-1390016	GM06990	blood:	n/a
47	chr6:1389966-1390016	HAEpiC	amniotic membrane:	n/a
48	chr6:1391207-1391257	ECC-1	luminal epithelium:	n/a
49	chr6:1391207-1391257	PFSK-1	brain:	n/a
50	chr6:1389367-1389417	PFSK-1	brain:	n/a

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr6:1389385..1390191-chr9:130213802..130214756,2	Hela-S3	cervix:
2	chr12:56861777..56862532-chr6:1390623..1391151,2	Hela-S3	cervix:

miRNA name	Chromosome Location	mirBase accession
hsa-miR-6720-3p	chr6:1390559-1390580	MIMAT0025851
hsa-miR-6720-5p	chr6:1390594-1390616	MIMAT0027345

Variant related genes	Relation type
FOXF2	TF binding region
ENSG00000261730	TF binding region
FOXF2	CpG island
ENSG00000261730	CpG island
ENSG00000176422	chromatin interactions
ENSG00000148356	chromatin interactions

Extended variants
information (count: 92 )
Associated
traits (count: 68 )

Variant overlapped rSNPs/rCNVs (count:92 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs565877167	chr6:1388936-1388937	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
2	rs199564443	chr6:1388979-1388980	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
3	rs191957759	chr6:1388997-1388998	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
4	rs574971417	chr6:1389027-1389028	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
5	rs111952129	chr6:1389089-1389090	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
6	rs115706877	chr6:1389091-1389092	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
7	rs138981573	chr6:1389123-1389124	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
8	rs182407313	chr6:1389162-1389163	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
9	rs527666766	chr6:1389167-1389168	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
10	rs374169339	chr6:1389178-1389179	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
11	rs573540531	chr6:1389183-1389184	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
12	rs1711972	chr6:1389188-1389189	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
13	rs546064105	chr6:1389221-1389222	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
14	rs563124073	chr6:1389233-1389234	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
15	rs561444465	chr6:1389235-1389236	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
16	rs531833132	chr6:1389260-1389261	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
17	rs527425390	chr6:1389297-1389298	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
18	rs548711159	chr6:1389319-1389320	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
19	rs562015374	chr6:1389322-1389323	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
20	rs527711274	chr6:1389330-1389331	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
21	rs546842295	chr6:1389394-1389395	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Weak transcription Enhancers	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
22	rs566641090	chr6:1389418-1389419	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
23	rs538954563	chr6:1389452-1389453	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
24	rs552081285	chr6:1389466-1389467	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
25	rs568749775	chr6:1389517-1389518	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
26	rs537504767	chr6:1389521-1389522	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
27	rs67407588	chr6:1389548-1389549	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
28	rs567690677	chr6:1389549-1389550	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
29	rs533567335	chr6:1389575-1389576	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
30	rs553763957	chr6:1389580-1389581	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
31	rs185797036	chr6:1389630-1389631	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
32	rs546518400	chr6:1389645-1389646	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
33	rs375229435	chr6:1389687-1389688	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
34	rs112930817	chr6:1389745-1389746	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
35	rs201933030	chr6:1389761-1389762	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
36	rs556754892	chr6:1390019-1390020	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
37	rs576714850	chr6:1390020-1390021	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
38	rs542317622	chr6:1390137-1390138	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs562183008	chr6:1390200-1390201	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs78728576	chr6:1390278-1390279	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs369263338	chr6:1390317-1390318	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs566600490	chr6:1390382-1390383	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs374633411	chr6:1390385-1390386	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs564550058	chr6:1390406-1390407	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs547098264	chr6:1390431-1390432	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs72667003	chr6:1390444-1390445	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs200419233	chr6:1390557-1390558	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs201914560	chr6:1390576-1390577	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	miRNA	n/a	Overlapped CNVs	n/a
49	rs376505537	chr6:1390599-1390600	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	miRNA	n/a	Overlapped CNVs	n/a
50	rs375888198	chr6:1390677-1390678	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:68)

Disease	PMID	Source
Chronic lymphocytic leukemia	21546498	CNVD
Myelofibrosis	22110671	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
Prader-willi syndrome	20588305	CNVD
Multiple myeloma	16616336	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Developmental delay	19490664	CNVD
Cancer	21183584	CNVD
Multiple Epiphyseal Dysplasia	20877625	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Glaucoma	18694899	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Prostate cancer	16573809	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Breast cancer	17603634	CNVD
Cancer	20164920	CNVD
Colorectal cancer	21297112	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Follicular lymphoma	20505157	CNVD
Glioblastoma multiforme	21080181	CNVD
Ewing''s sarcoma	21437220	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Leukemia	21518781	CNVD
Cancer	21637783	CNVD
Facial dysmorphism	22105932	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Bladder cancer	19088036	CNVD
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Biliary cancer	19435499	CNVD
Malaria	21533027	CNVD
Retinoblastoma	19183342	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Prostate cancer	18632612	CNVD
Myelodysplastic syndrome	21251322	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Breast cancer	21858162	CNVD
Breast cancer	21364760	CNVD
Lung cancer	18438408	CNVD
Bladder cancer	21909424	CNVD
Multiple myeloma	17550852	CNVD
Ewing''s sarcoma	17952124	CNVD
Cancer	20164919	CNVD
Gastric cancer	16891809	CNVD
Ovarian cancer	21781307	CNVD
small cell lung cancer	20016488	CNVD
Autism	22495311	CNVD
Autism	21448237	CNVD

Chromatin state (count:425 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:1382600-1389000	Weak transcription	Right Atrium	heart
2	chr6:1385600-1389400	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
3	chr6:1386800-1389200	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
4	chr6:1387000-1389400	Active TSS	Rectal Smooth Muscle	rectum
5	chr6:1387200-1389800	Bivalent/Poised TSS	Fetal Intestine Small	intestine
6	chr6:1387400-1390800	Bivalent/Poised TSS	Colonic Mucosa	Colon
7	chr6:1387600-1390800	Active TSS	NHLF	lung
8	chr6:1387800-1389000	Bivalent Enhancer	ES-I3 Cell Line	embryonic stem cell
9	chr6:1387800-1389200	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
10	chr6:1387800-1389200	Bivalent Enhancer	Primary T helper cells PMA-I stimulated	--
11	chr6:1387800-1389400	Bivalent Enhancer	Primary T regulatory cells fromperipheralblood	blood
12	chr6:1387800-1389600	Bivalent Enhancer	Primary T helper 17 cells PMA-I stimulated	--
13	chr6:1387800-1389600	Bivalent/Poised TSS	Fetal Intestine Large	intestine
14	chr6:1387800-1389600	Bivalent/Poised TSS	Rectal Mucosa Donor 29	rectum
15	chr6:1387800-1392800	Active TSS	Colon Smooth Muscle	Colon
16	chr6:1388000-1389200	Bivalent Enhancer	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
17	chr6:1388000-1389200	Bivalent Enhancer	Primary T helper naive cells fromperipheralblood	blood
18	chr6:1388000-1389200	Weak transcription	Gastric	stomach
19	chr6:1388000-1389400	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
20	chr6:1388000-1389400	Bivalent Enhancer	H9 Derived Neuron Cultured Cells	ES cell derived
21	chr6:1388000-1389400	Bivalent Enhancer	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
22	chr6:1388000-1389400	Bivalent Enhancer	iPS DF 6.9 Cell Line	embryonic stem cell
23	chr6:1388000-1389400	Bivalent Enhancer	Cortex derived primary cultured neurospheres	brain
24	chr6:1388000-1389600	Bivalent Enhancer	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
25	chr6:1388000-1389600	Bivalent Enhancer	Primary B cells from peripheral blood	blood
26	chr6:1388000-1389600	Bivalent Enhancer	Primary T cells effector/memory enriched fromperipheralblood	blood
27	chr6:1388000-1389600	Bivalent/Poised TSS	Brain Dorsolateral Prefrontal Cortex	brain
28	chr6:1388000-1390600	Enhancers	Spleen	Spleen
29	chr6:1388000-1395200	Bivalent/Poised TSS	Rectal Mucosa Donor 31	rectum
30	chr6:1388200-1389000	Bivalent Enhancer	Primary T helper cells fromperipheralblood	blood
31	chr6:1388200-1389200	Bivalent Enhancer	iPS DF 19.11 Cell Line	embryonic stem cell
32	chr6:1388200-1394400	Bivalent/Poised TSS	Fetal Lung	lung
33	chr6:1388400-1389000	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
34	chr6:1388400-1389600	Flanking Active TSS	IMR90 fetal lung fibroblasts Cell Line	lung
35	chr6:1388400-1389600	Bivalent Enhancer	Primary T helper memory cells from peripheral blood 1	blood
36	chr6:1388400-1389600	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
37	chr6:1388400-1389600	Bivalent Enhancer	Fetal Muscle Trunk	muscle
38	chr6:1388400-1389800	Bivalent Enhancer	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
39	chr6:1388400-1389800	Bivalent Enhancer	Fetal Muscle Leg	muscle
40	chr6:1388400-1390000	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
41	chr6:1388400-1390600	Active TSS	Lung	lung
42	chr6:1388400-1391400	Bivalent/Poised TSS	H9 Cell Line	embryonic stem cell
43	chr6:1388600-1389000	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
44	chr6:1388600-1389000	Flanking Bivalent TSS/Enh	Brain Cingulate Gyrus	brain
45	chr6:1388600-1389000	Weak transcription	Pancreas	Pancrea
46	chr6:1388600-1389200	Bivalent Enhancer	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
47	chr6:1388600-1389200	Bivalent Enhancer	Adipose Nuclei	Adipose
48	chr6:1388600-1389200	Bivalent Enhancer	HepG2	liver
49	chr6:1388600-1389200	Bivalent Enhancer	NH-A	brain
50	chr6:1388600-1389400	Bivalent Enhancer	Primary T helper memory cells from peripheral blood 2	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links